Strateos Overview

  • Founded
  • 2012

Founded
  • Status
  • Private

  • Employees
  • 152

Employees
  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $56M

  • Investors
  • 25

Strateos General Information

Description

Developer of a robotic cloud lab platform designed to accelerate drug discovery and synthetic biology research. The company's platform automates chemistry, biology, and tissue analysis into closed-loop robotic labs that accelerate drug discovery programs, enabling pharmaceutical partners to rapidly and efficiently discover new drug candidates.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Enterprise Systems (Healthcare)
Primary Office
  • 3565 Haven Avenue
  • Suite 3
  • Menlo Park, CA 94025
  • United States
+1 (650) 000-0000

Strateos Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Strateos Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series B) 08-Jun-2021 $56M 000.00 00000 Completed Generating Revenue
3. Later Stage VC (Series A) 03-Jun-2019 000.00 000.00 00000 Completed Startup
2. Seed Round $13M $13M 0000 Completed Startup
1. Merger of Equals 03-Jun-2019 Completed Startup
To view Strateos’s complete valuation and funding history, request access »

Strateos Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 00,000,000 00.000000 00.0 00.0 00.0 00 00.0 00.000
Series A3 0,000,000 00.000000 00.0 00.00 00.00 00 00.00 0.000
Series A2 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series A1 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series A 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00
Seed 2 7,260,466 $0.000100 $0.09 $1.18 $1.18 1x $1.18 8.41%
Seed 1 4,190,792 $0.000100 $0.09 $1.11 $1.11 1x $1.11 4.86%
To view Strateos’s complete cap table history, request access »

Strateos Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a robotic cloud lab platform designed to accelerate drug discovery and synthetic biology research. The comp
Discovery Tools (Healthcare)
Menlo Park, CA
152 As of 2023
000.00
0000 0000-00-00
00000000000 000.00

000000

m veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commod
000000000 00000 (000
Abingdon, United Kingdom
00 As of 0000
00.000
0000000000 0 00.000

000000

dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco
0000000000000
London, United Kingdom
0 As of 0000
00.000
000000&0 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Strateos Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Arctoris Venture Capital-Backed Abingdon, United Kingdom 00 00.000 0000000000 0 00.000
0000000 00000000 Formerly VC-backed London, United Kingdom 0 00.000 000000&0 00.000
00000000 Private Equity-Backed Chicago, IL 000000000000
You’re viewing 3 of 3 competitors. Get the full list »

Strateos Patents

Strateos Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230004886-A1 Systems and methods for performing experiments at remote laboratories Pending 02-Jul-2021 00000000000
US-20230004885-A1 Systems and methods for processing experimental workflows at remote laboratories Pending 02-Jul-2021 00000000000
US-20230004909-A1 Systems and methods for processing experimental requests at remote laboratories Pending 02-Jul-2021 000000000000
US-20230003753-A1 Systems and methods for managing experimental requests at remote laboratories Pending 02-Jul-2021 000000000000
US-20220362773-A1 Devices and methods for handling biological specimens Pending 17-May-2021 B01L3/50855
To view Strateos’s complete patent history, request access »

Strateos Executive Team (5)

Name Title Board Seat Contact Info
Mark Fischer-Colbrie President, Board Member & Chief Executive Officer
Christopher Krueger Chief Financial Officer
David Lynch Ph.D Chief Business Officer
Jason Pontin Chairman
Mara Aspinall Vice Chairman
To view Strateos’s complete executive team members history, request access »

Strateos Board Members (5)

Name Representing Role Since
Jason Pontin Self Chairman 000 0000
Jeffrey Finer Ph.D Transcriptic Chairman 000 0000
Joshua Wolfe Lux Capital Board Member 000 0000
Mara Aspinall Self Vice Chairman 000 0000
You’re viewing 4 of 5 board members. Get the full list »

Strateos Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Strateos Investors (25)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
500 Global Venture Capital Minority 000 0000 000000 0
Ally Bridge Group PE/Buyout Minority 000 0000 000000 0
Alumni Ventures Venture Capital Minority 000 0000 000000 0
Baidu Ventures Corporate Venture Capital Minority 000 0000 000000 0
Bennu Venture Group Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 25 investors. Get the full list »

Strateos Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000000 03-Jun-2019 0000000000 Laboratory Services (Healthcare)
3Scan 26-Apr-2019 Merger/Acquisition Diagnostic Equipment
To view Strateos’s complete acquisitions history, request access »